CDMOs are expanding to provide integrated services, enhancing outsourcing appeal. Sustainability mandates boost adoption of advanced systems, and growth is pronounced in excipient innovation and ...

Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially viable dosage forms, rarely a simple process. Image Credit: ...

Polymeric microspheres play a pivotal role in advancing high-potency therapeutics, offering controlled release capabilities. Significant progress in biotechnology and combinatorial chemistry has ...

Researchers at the University of Toronto say they have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine ...

This interview addresses the challenges and complexities of developing and manufacturing controlled-release drug formulations. Could you introduce yourself and your expertise in drug development and ...

CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable ...

Type-3 New Drug Applications, focusing on new dosage forms, dominate the 505(b)(2) pathway approvals, with injectable formulations being the largest category. Stability and manufacturing consistency ...

Poor drug solubility has become a challenge for pharmaceutical companies, with an approximation of 40% of drugs in their developing stages demonstrating problems with drug solubility. Additionally, ...

Proteolysis-targeting chimeras (PROTACs), particularly those incorporating the von Hippel–Lindau (VHL) E3 ligase ligand, present significant physicochemical challenges due to their large molecular ...